BALSTILIMAB
UNII 1Q2QT5M7EO

Substance Identification & Data

This profile provides standardized clinical and technical data for Balstilimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1Q2QT5M7EO.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2148321-77-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

1Q2QT5M7EO

CAS Registry Number

2148321-77-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BALSTILIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C136465

National Cancer Institute reference terminology for clinical and research data.

INN ID

10993

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-66

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Balstilimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BALSTILIMAB

Common Names & Synonyms

A FULLY HUMAN IGG4 MONOCLONAL ANTAGONIST ANTIBODY DIRECTED AGAINST PROGRAMME D CELL DEATH PROTEIN 1 (PD-1) WITH POTENTIAL IMMUNE CHECKPOINT INHIBITORY AND ANTINEOPLASTIC ACTIVITIES

ANTI-PD1 MONOCLONAL ANTIBODY AGEN2034

BALSTILIMAB [INN]

BALSTILIMAB [USAN]

BALSTILIMAB [WHO-DD]

IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL AGEN2034 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AGEN2034 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), HOMO SAPIENS MONOCLONAL ANTIBODYGAMMA4 HEAVY CHAIN HOMO SAPIENS (1-440) (VH (HOMO SAPIENS IGHV3-33*01 (100%)-(IGHD)-IGHJ1*01 (100%)) (8.8.6) (1-113)-HOMO SAPIENS IGHG4*01 (CH1 (114-211), HINGE S10>P (221) (212-223), CH2 (224-333), CH3 (334-438), CHS (439-440)) (114-440)), (127-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') (V-KAPPA (HOMO SAPIENS IGKV3-15*01 (100%)-IGKJ1*01 (100.0%)) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214'))DIMER (219-219'':222-222'')-BISDISULFIDE

Technical Codes

AGEN2034

AGEN-2034

External Clinical & Regulatory Resources

Previous UNII1Q2P9TO9Q7

Next UNII1Q2Z3U96CG